www.medskool.com
 

Google
 
Web www.MedSkool.Net
 
http://www.medskool.net/index.html
http://www.medskool.net/circulatory/index.html
http://www.medskool.net/excretory/index.html
http://www.medskool.net/integumentary/index.html
http://www.medskool.net/reproductive/index.html
http://www.medskool.net/respiratory/index.html
 
 
 
 
 
 
 
 

 

 
 

Pulmonary Vascular Disease

 

Pulmonary Embolism
 

A variety of materials can embolize pulmonary vasculature:

  • Air (ex: due to an IV)
  • Bone marrow (ex: due to fracture)
  • Amniotic fluid
  • Talc (ex: injection drug users)
  • Thrombin clots à clots form in the deep veins of the legs, pelvic extremity vessels, or upper extremity vessels – clots can break loose & embolize pulmonary vasculature

Typical Case of Pulmonary Embolism:

36-year-old man developed acute onset of shortness of breath. He noted the breathlessness as his airplane was landing in Newark airport after a transcontinental air flight. Of note, 8 weeks prior to the onset of dyspnea the patient sustained a fracture of his right tibia. A cast was removed from the affected extremity 2 days prior to the flight to Newark. In addition to dyspnea, he also noted right-sided pleuritic chest pain. While leaving the plane the patient experienced a brief syncopal episode. He was brought to the UH emergency room.

On PE the patient complained of right-sided pleuritic chest pain. He appeared mildly anxious. The respiratory rate was 22 bpm, BP 138/85, P 102 regular. The rest of the patient’s physical examination was entirely within normal limits. CXR was WNL. ABGs on RA: pH 7.46, pCO2 33 (slightly decreased), pO2 72. V/Q scan of lungs showed several matched segmental defects (indicates intermediate probability for pulmonary embolism). Doppler examination of right leg was positive for deep vein thrombosis


Why is it important to diagnose Pulmonary Embolism?

  • Incidence > 600,000 per year in the US
    • 11% of these individuals will die within 1 hour
    • 89% have a survival of > 1 hour
      • In 71% of these individuals a diagnosis is not made à 70% of these individuals will survive & 30% will die
      • In 29% of these individuals a diagnosis is made & therapy is instituted à 92% of these individuals will survive & 8% will die
  • Untreated mortality ~ 30%
  • Treated mortality ~ 2.1%
  • Diagnosis frequently missed
 
 

Basically we want to try to prevent people from getting a pulmonary embolism if possible. We also want to think about a diagnosis of pulmonary embolism & make it rapidly so that treatment can be instituted.  


Factors which Predispose to Thromboembolism:

  • Local trauma to the vessel wall
  • Hypercoagulability
  • Stasis

 


Risk Factors for Developing Pulmonary Embolism:

Risk Factor

Hypercoagulability

Stasis

Trauma

History of previous venous thrombosis

X

 

 

Major surgery

 

X

X

Cancer

X

X

 

Obesity

 

X

 

Trauma

 

 

X

Fracture of hip or legs

 

X

X

Pregnancy

X

X

 

MI, stroke, CHF, prolonged immobilization, burns

 

X

 

Estrogen therapy

X

 

 

Genetic or acquired thrombophilia (antithrombin III deficiency, protein S or C deficiencies, Factor V Leiden, anticardiolipin antibody syndrome, lupus anticoagulant)

X

 

 


 
Diagnosing Pulmonary Embolism:

·         Clinical suspicion

·         Ventilation-perfusion (V/Q) lung scan à indeterminate in 85% of cases (not a good test)

·         Spiral CT scan (with dye & rapid sequencing) à supplanting V/Q scan as the diagnostic test of choice

·         Doppler or impedance plethysmography of legs (ultrasound approach)

·         Quantitative d-dimer assay (performed by ELISA) à negative result excludes diagnosis – it’s a non-specific blood test

·         Pulmonary angiography à “gold standard” – patients are often considered too unstable to perform this test 
 

Pulmonary Hypertension

Pressure = Flow x Resistance (this is equivalent to Ohm’s Law)

Pulmonary artery pressure is increased (pulmonary hypertension) when:

·         The flow of blood through the pulmonary circulation is increased and/or

·         The resistance in the pulmonary circulation is increased

Pulmonary Artery vs. Systemic Artery Pressures

·         Pulmonary artery à systolic is 15 – 30mm, diastolic is 3 – 12 mm, & the mean is < 20 mm – high capacity & low pressure system

·         Systemic artery à systolic is 90 – 130mm, diastolic is 60 – 85 mm, & the mean is < 115 mmHg

Pulmonary hypertension à the mean pulmonary artery pressure is > 25 mmHg at rest or > 30 mmHg with exercise
 

Classification of Pulmonary Hypertension:

Type

Mechanism

Example

Passive

Impedance to pulmonary venous drainage

Mitral stenosis, pulmonary veno-occlusive disease

Hyperkinetic

Increased pulmonary blood flow

Atrial septal defect, ventricular septal defect

Obstructive

Impedance to flow through large pulmonary arteries

Pulmonary thromboembolism, unilateral absence or stenosis of a pulmonary artery

Obliterative

Impedance to bloodflow through small pulmonary arteries

Primary pulmonary hypertension, collagen vascular diseases

Vasoconstrictive

Impedance to flow from hypoxia-induced vasoconstriction

Chronic mountain sickness, sleep apnea syndrome

Polygenic

Two or more of the causes listed above

Chronic obstructive pulmonary disease (obliterative & vasoconstrictive), interstitial pulmonary fibrosis (obliterative & vasoconstrictive)

 

What are the diagnostic criteria for Primary Pulmonary Hypertension (PPH)?

·         Mean PAP > 25 mmHg at rest or

·         Mean PAP > 30 mmHg with exercise

·         Exclusions à left-sided cardiac valvular disease, myocardial disease, congenital heart disease, primary respiratory diseases, connective tissue diseases, chronic thromboembolic diseases

 

Pulmonary Vascular Diseases similar to Primary Pulmonary Hypertension:

·         Portal hypertension

·         Infection with HIV

·         Cocaine inhalation associated pulmonary hypertension

·         Appetite-suppressant drug associated pulmonary hypertension à fenfluramine and dexfenfluramine & amphetamines

 

Incidence of PPH à 1 – 2 cases per million per year – approx. 6% of these cases are familial (its an autosomal dominant trait) & the rest are spontaneous

 

Pathogenesis of PPH:

·         Altered function of pulmonary vascular epithelium à what are the potential factors, which have been proposed to explain the altered function?

o        Increased activity of thromboxane and/or diminished activity of prostacyclin (vasodilator)

o        Impaired synthesis of NO by the endothelium

o        Enhanced production of endothelium-derived endothelin (vasoconstrictor) 

Diagnosis of PPH:

·         Symptoms

o        Dyspnea (60%)

o        Fatigability

o        “Angina” (atypical chest pain)

o        Syncope

o        Raynaud’s phenomenon à constriction of blood vessels in the fingers

·         Evaluation

o        Echocardiography à rule out congenital, valvular, or myocardial disease and to estimate PAP

o        V/Q scan

o        Pulmonary function tests

o        Serological studies for connective tissue disease

o        Consider right sided heart catheter


Back to the Respiratory System Index

 

 


Navigation:

MedSkool.Net Home - Circulatory - Excretory - Integumentary - Respiratory
MedSkool.Net Sitemap
 

 

All Content provided on or through MedSkool.Net (i) is provided for informational purposes only, (ii) is not a substitute for professional medical advice, care, diagnosis or treatment, and (iii) is not designed to promote or endorse any medical practice, program or agenda or any medical tests, products or procedures. The Site does not contain information about all diseases, nor does this Site contain all information that may be relevant to a particular medical or health condition. You should not use any Content for diagnosing or treating a medical or health condition. You should carefully read all information provided by the manufacturers of any products advertised or promoted on or through the Site and displayed on or in the associated product packaging and labels before purchasing and/or using such products. If you have or suspect that you have a medical problem, you should contact your professional healthcare provider through appropriate means. You agree that you will not under any circumstances disregard any professional medical advice or delay in seeking such advice in reliance on any Content provided on or through the Site. Reliance on any such Content is solely at your own risk.    Full Disclaimer

Copyright © 2006 www.MedSkool.Net - All Rights Reserved - Trademarks used herein are property of their respective owners